Become a member
Quick Registration
Full Registration Benefits -
Free Homepages for Doctors
Free Homepages for Hospitals
Free Homepages for Medical Conference
Free Homepages for NGO's
Personal Health Record Creation
Access to all Medical Slides
Access to all Jobs & Products Sale
Lung Disease LAM Symptoms Alleviated With Sirolimus Therapy | |
|
| |
Sirolimus, a drug currently used to help prevent transplant rejection, can improve lung function and quality of life in individuals living with the lung disease lymphangioleiomyomatosis (LAM), according to the results of a new study sponsored and conducted in part by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health.
"Efficacy and Safety of Sirolimus in Lymphangioleiomyomatosis," will be published online March 16 in the New England Journal of Medicine.
LAM is a rare and progressive lung disease in which cancer-like cells infiltrate the lung, leading to shortness of breath, coughing, chest pain, and in many cases eventual respiratory failure. LAM affects almost exclusively women, primarily of child-bearing age. Though only around 1,000 women in the U.S. have diagnosed LAM, there may be many more as the disease is not well-diagnosed.
This international study, led by the University of Cincinnati, recruited 89 LAM patients to test sirolimus, a drug that can suppress rapid cell growth by blocking an overactive protein called mTOR. Sirolimus is already used as an immune suppressant for organ transplants and is also being tested as a cancer drug. mTOR is also highly active in the invading cells that cause LAM.
The participants took daily oral doses of sirolimus or placebo over 12 months and had their lung function measured at regular intervals. The primary measurement was forced expiratory volume (FEV1), or the volume of air that can be forced out in the first second after taking a deep breath. The sirolimus group displayed stable FEV1 levels over the 12-month treatment period, compared to a roughly 12% decline in the placebo group. The sirolimus group also showed other clinical improvements, and reported a greater ability to carry out day-to-day functions and a better quality of life.
Following the treatment period, the study participants underwent 12-months of observation. After stopping sirolimus, the decline in lung function was similar in both the sirolimus and placebo groups, indicating treatment effectiveness likely requires continued use.
Source-Eurekalert
| |
|
|
More News on: Reiki and Pranic Healing, Sarcoidosis / Besnier - Boeck disease, Asbestosis , Cystic Fibrosis, Pneumoconiosis, Silicosis
 Comment & Contribute
|
Related Links
Severe Lung Disease in Patients With Diabetes may be Prevented by Leptin Resistance
A study conducted by researchers in Chicago says that resistance to leptin, a protein that plays a key role in regulating metabolism and appetite, ...
Lack of Vitamin D Tied to Onset of Autoimmune Lung Disease
Vitamin D deficiency could be linked to the development and severity of certain autoimmune lung diseases, according to a new study. ...
Risk for Lung Disease Increased by Smoking
Approximately one out of every twelve adult smokers have abnormal lung densities present on chest computed tomography (CT) images suggestive of ...
Research Says Protein Involved in Cystic Fibrosis also Plays Role in Emphysema, Chronic Lung Disease
A protein involved in cystic fibrosis (CF) also regulates inflammation and cell death in emphysema and may be responsible for other chronic lung ...
Drug Related News
EU Agency Says Acne Pill Benefits Outweigh Blood Clot Risk
The benefits of acne drug Diane-35, also widely used as a contraceptive, outweigh the risk of developing blood clots in the veins, said Europe's ...
Statins Cut Exercise Benefits
Simvastatin a type of statin was found to hinder the positive effects of exercise for obese and overweight adults. Statins, the ...
New Drug Enhances Radiation Treatment for Brain Cancer
A novel drug may significantly help increase the effectiveness of radiation therapy for the most deadly form of brain cancer, say scientists at ...
Experts Issue Warning Against Online Sexual Enhancement Pills
Health experts have warned people against purchasing sexual enhancement pills from stores or from the internet as they often are a dangerous ...
Powerful Painkiller Discovered in Canadian Black Market
A Can$3 million (US$3 million) drug stash was found by Montreal police that included their first ever black market discovery of a synthetic drug that ...
Medwonders Health Network
- Health News Index
|
|
- News Quick Links
| News Categories: |
| » | EU Agency Says Acne Pill Benefits Outweigh Blood Clot Risk |
| » | Reduce Ambien's Dose to Avoid Drowsy Driving |
| » | Statins Cut Exercise Benefits |
| » | New Drug Enhances Radiation Treatment for Brain Cancer |
| » | Experts Issue Warning Against Online Sexual Enhancement Pills |
| More Drug News | |
|
Ask an Expert
